RUNX1 and acute leukemia: In contrast, GSK-3 inhibition did not produce antiproliferative effects and did not increase expression of p27Kip1 in acute leukemia cells with other gene rearrangements, including TEL-AML1, E2A-HLF, and E2A-PBX1 (49).